John love to see it thanks man! Please cover AQST stock if you get time. They have price targets of $12,16 and 24 now which is a little crazy. Maybe it can hit $6 again. It was at $6.40 then they got rejected for libervant in 2021 and now it looks like it will be approved in a few months which could be a billion dollar product. Game changer medication and the stock also has big short squeeze potential as well.
@@Financewith_John Aquestive Therapeutics, with an FDA decision date set for April 28th on Libervant, could potentially see significant stock movement, similar to a previous instance where their stock doubled in the three months leading up to an FDA decision date.
